Claus Crone Fuglsang

As the Vice President of BioEnergy Research and Development, Claus Fuglsang is leading Novozymes research in this area and he oversees a portfolio of projects with more than 150 employees.  As such, Claus has played a big part in the development of the first commercial cellulosic ethanol enzymes, Novozymes’ Cellic® CTec range.

Claus has worked in Novozymes since 1993 first as a research scientist, then  as a manager and since 2002 as a Director responsible for Novozymes’ Protein Chemistry area and Pharmaceutical Protein Development.  In 2008, he transferred from Denmark to the United States.

Claus has a Masters degree in Biochemistry from the University of Copenhagen and an MBA from Heriot-Watt University, Edinburgh Business School.